Skip to main
MLYS
MLYS logo

MLYS Earnings Dates & Reports

MLYS Most Recent Earnings

Report DateNov 10, 2025
Period EndingQ3 2025
Est. EPS-$0.63
Actual EPS-$0.52
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MLYS Earnings per Share (EPS) History

Signup for full access
Browse free

MLYS Latest Earnings

The value each MLYS share was expected to gain vs. the value each share gained.

MLYS reported its most recent earnings on Nov 10, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.52. This exceeded analysts' expectations of -$0.63 by 17.46%, marking a Beat.

For comparison, Mineralys Therapeutics Inc reported EPS of -$1.13 in the same quarter last year.

The company is expected to announce its next earnings report on 02/11/2026, with analysts projecting an EPS of -$0.54.

MLYS Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Mar 17, 2026
-$0.54Next earnings call Feb. 11, 2026
Q3 2025Nov 10, 2025
-$0.63-$0.52-17.46%
DeckReportListen
Q2 2025Aug 12, 2025
-$0.76-$0.66-13.16%
DeckReportListen
Q1 2025May 12, 2025
-$0.98-$0.79-19.39%
DeckReportListen
Q4 2024Feb 12, 2025
-$1.08-$0.98-9.26%
DeckReportListen
View all

MLYS Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Mineralys Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 10, 2025
Aug 12, 2025
May 12, 2025
Feb 12, 2025

MLYS Earnings FAQs

MLYS last reported earnings on Nov 10, 2025 for Q3 2025, posting an EPS of -$0.52, which Beat the estimate of -$0.63 by 17.46%.

For Q3 2025, MLYS reported an EPS of -$0.52, exceeding analysts' estimate of -$0.63 by 17.46%.

For Q3 2025, MLYS Beat expectations with an actual EPS of -$0.52 vs. an estimated EPS of -$0.63.

Following the last earnings report on Nov 10, 2025, MLYS's stock price moved — from — to —.

The next MLYS earnings call is scheduled for Feb. 11, 2026, where executives will discuss financial results and outlook.

Mineralys Therapeutics Inc (MLYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.